⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

IONS

Ionis Pharmaceuticals, Inc.

Healthcare · Biotechnology

42.93USD

-0.9800 (-2.23%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on IONS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 42.93
P/E—
Dvd Ind Yld0.0%
P/B16.22
P/S8.2
Curr EV/T12M EBITDA-12.5
Mkt Cap (USD)7.1B
Curr EV (USD)7.2B
2)

Per Share Data

EPS T12M-3.46
DPS—
Bk Val Per Sh2.66
Rev/Sh5.28
Cash/Sh12.65
Curr Shares Out166.2M
FCF/Sh-3.39
3)

Cash Flow Analysis

P/CF-14.4
Curr P/FCF-12.7
CF/NI0.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-56.8%
Eff Interest Rate1.1%
4)

Growth Potential

Dil EPS 1Y Gr21.7%
Cap 1Y Gr25.6%
BPS 1Y Gr-22.3%
R&D To Sales20.2%
Retention Rate100.0%
Rev 1Y Gr33.8%
FCF 1Y Gr41.4%
Assets 1Y Gr17.3%
5)

Profitability

EBITDA-0.6B
EBIT-0.6B
Operating Margin-68.0%
Pretax Margin-64.3%
Net Margin-64.7%
ROA-18.9%
ROE-105.5%
ROC—
Asset Turnover0.29
6)

Structure

Current Ratio7.89
Quick Ratio6.85
Debt/Assets58.8%
Debt/Com Eq400.3%
Net Debt/EBITDA-2.42
Tot Debt/Capital80.0%
Gross Margin98.2%
EBIT/Int Exp-31.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.